Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen's CEO Spending Spree Comes At The Expense Of Shareholders
Biogen's CEO Spending Spree Comes At The Expense Of Shareholders
Biogen's CEO Spending Spree Comes At The Expense Of Shareholders
Submitted by
admin
on June 13, 2015 - 9:38am
Source:
Seeking Alpha
News Tags:
George Scangos
Biogen
Alzheimer's disease
aducanumab
Headline:
Biogen's CEO Spending Spree Comes At The Expense Of Shareholders
Do Not Allow Advertisers to Use My Personal information
